Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Heymans

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Biochemical Pharmacology|March 22, 1996
4-Alkoxybenzamidines as new potent phospholipase A2 inhibitorsM Aitdafoun, C Mounier, F Heymans, et al.
Journal of Lipid Mediators and Cell Signalling|July 1, 1997
A new phospholipase A2 inhibitor, unrelated to substrate analogues: kinetic characterization of the inhibition of secretory phospholipases A2 by PMS 832C Binisti, C Mounier, E Touboul, et al.
Journal of Lipid Mediators and Cell Signalling|January 1, 1997
Structure-activity relationships in platelet activating factor. 9. From PAF-antagonism to PLA2 inhibitionC Binisti, E Touboul, C Mounier, et al.
Agents and Actions|December 1, 1982
Radio-labelling of 1-O-alkyl, 2-O-acetyl, sn-glycero-3-phosphorylcholine, 1-O-(9,10-di3H)-octadecyl PAF-acetherJ L Morgat, J Roy, B Wichrowski, et al.
Journal of Medicinal Chemistry|February 1, 1988
Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteresB Wichrowski, S Jouquey, C Broquet, et al.
Journal of Lipid Mediators and Cell Signalling|January 1, 1997
Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazinesF Tavet, A Lamouri, F Heymans, et al.
Journal of Lipid Mediators|July 1, 1989
PAF-receptor. 1. 'Cache-oreilles' effect of selected high-potency platelet-activating factor (PAF) antagonistsG Dive, J J Godfroid, J Lamotte-Brasseur, et al.
International Journal of Sports Physical Therapy|April 8, 2022
Effect of Low-Load Blood Flow Restriction Training After Anterior Cruciate Ligament Reconstruction: A Systematic ReviewBaris B Koc, Alexander Truyens, Marion J L F Heymans, et al.
Journal of Lipid Mediators|February 1, 1992
Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofuransE Favre, F Heymans, C Redeuilh, et al.
World Journal of Orthopedics|June 28, 2023
Cost-effectiveness of patient specific <i>vs</i> conventional instrumentation for total knee arthroplasty: A systematic review and meta-analysisIsobel M Dorling, Lars Geenen, Marion J L F Heymans, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Biochemical Pharmacology|March 22, 1996
4-Alkoxybenzamidines as new potent phospholipase A2 inhibitorsM Aitdafoun, C Mounier, F Heymans, et al.
Journal of Lipid Mediators and Cell Signalling|July 1, 1997
A new phospholipase A2 inhibitor, unrelated to substrate analogues: kinetic characterization of the inhibition of secretory phospholipases A2 by PMS 832C Binisti, C Mounier, E Touboul, et al.
Journal of Lipid Mediators and Cell Signalling|January 1, 1997
Structure-activity relationships in platelet activating factor. 9. From PAF-antagonism to PLA2 inhibitionC Binisti, E Touboul, C Mounier, et al.
Agents and Actions|December 1, 1982
Radio-labelling of 1-O-alkyl, 2-O-acetyl, sn-glycero-3-phosphorylcholine, 1-O-(9,10-di3H)-octadecyl PAF-acetherJ L Morgat, J Roy, B Wichrowski, et al.
Journal of Medicinal Chemistry|February 1, 1988
Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteresB Wichrowski, S Jouquey, C Broquet, et al.
Journal of Lipid Mediators and Cell Signalling|January 1, 1997
Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazinesF Tavet, A Lamouri, F Heymans, et al.
Journal of Lipid Mediators|July 1, 1989
PAF-receptor. 1. 'Cache-oreilles' effect of selected high-potency platelet-activating factor (PAF) antagonistsG Dive, J J Godfroid, J Lamotte-Brasseur, et al.
International Journal of Sports Physical Therapy|April 8, 2022
Effect of Low-Load Blood Flow Restriction Training After Anterior Cruciate Ligament Reconstruction: A Systematic ReviewBaris B Koc, Alexander Truyens, Marion J L F Heymans, et al.
Journal of Lipid Mediators|February 1, 1992
Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofuransE Favre, F Heymans, C Redeuilh, et al.
World Journal of Orthopedics|June 28, 2023
Cost-effectiveness of patient specific <i>vs</i> conventional instrumentation for total knee arthroplasty: A systematic review and meta-analysisIsobel M Dorling, Lars Geenen, Marion J L F Heymans, et al.
Pageof 4